Albert Seow, MD
Vascular & Interventional Radiology · Louisville, KYNPI 1326042763
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $295 and has fallen 90.1% since, to $29 in 2024. That places this record below the midpoint for vascular & interventional radiology clinicians in KY, where the typical reported total is $4,163.
Across 36 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$68
- E.r. Squibb & Sons, L.L.C.$62
- Amgen$59
- GE HealthCare$58
- Incyte Corporation$36
- Bristol Myers Squibb$32
- plus $274 from 13 others
What the payments were for
- Food & beverage$57597%
- Education$153%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 4 | $68 |
| E.r. Squibb & Sons, L.L.C. | 3 | $62 |
| Amgen | 4 | $59 |
| GE HealthCare | 3 | $58 |
| Incyte Corporation | 3 | $36 |
| Bristol Myers Squibb | 2 | $32 |
| Eisai Inc. | 2 | $32 |
| Novartis | 2 | $32 |
| Boston Scientific | 1 | $29 |
| Bayer | 2 | $28 |
| Foundation Medicine, Inc. | 2 | $23 |
| Johnson & Johnson | 1 | $21 |
| Astellas Pharma US Inc | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| AstraZeneca | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Mirati Therapeutics, Inc. | 1 | $15 |
| Rigel Pharmaceuticals, Inc. | 1 | $15 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $12 |
How this compares
$590 in reported general payments places this provider in the 15th percentile of 41 vascular & interventional radiology providers in Kentucky.
See all vascular & interventional radiology providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular & interventional radiology in Louisville
- Nana Ohene-BaahLouisville$33K
- Brian WongLouisville$13K
- Bryan GlaenzerLouisville$7K
- Trevor HollandLouisville$6K
- Chandresh ShahLouisville$5K
- Cameron GhaziLouisville$5K
- Lawrence KellyLouisville$3K
- Sohail ContractorLouisville$2K
- Melissa PottsLouisville$2K
- Michael ChorneyLouisville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.